George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: 0.50 (1.64%)
Spread: 2.00 (6.667%)
Open: 31.00
High: 31.00
Low: 31.00
Prev. Close: 30.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement: Trading update

17 Mar 2017 18:25

RNS Number : 8736Z
Ilika plc
17 March 2017
 

A number of non material typographical changes have been made to the 'Trading update' announcement released on 17 March 2017 at 07.00 under RNS No 7455Z.

 

The changes are identified with an asterisk (*).

 

The full amended text is shown below.

 

17 March 2017

Ilika plc

("Ilika" or the "Company")

 

Trading update

 

Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces the following update on trading.

 

Revenue update

Since its last trading update in November 2016, the Company has announced four significant commercial deals, which are resulting in a strong ramp-up of revenue relative to 2015/16 and which will continue to support revenue growth into 2017/18. We expect to start 2017/18 with a record level of revenue commitments amounting to around £1.8m.

 

Ilika's stated business aim is to add licensing revenue to the development revenue it currently generates. While levels of interest are encouraging, predicting the timing of when these licenses will generate revenue remains a significant forecasting challenge for the Company. Given our proximity to the end of Ilika's current financial year and the duration of negotiations with OEM potential licensees, it seems increasingly likely that revenue from licensing may first have an impact in 2017/18.

 

Stereax roadmap update

Ilika has continued to develop its Stereax intellectual property in accordance with its roadmap, which it updates in line with feedback from its pipeline of development partners. Earlier this month, Ilika confirmed that it had secured a partnership with a bioelectronics company*, focused on optimising the Stereax platform for use in miniature medical implants*. Bioelectronics is a rapidly developing market with large opportunities that match the unique benefits that Stereax offers. Stereax's high volumetric energy density, manufacturability at mm-scale and the ability to deliver pulses of power are ideal for such devices. *

 

Towards the end of last year, Ilika announced the start of a funded collaborative project with Sharp Laboratories of Europe ("Sharp") to create a device consisting of an integrated StereaxTM solid-state battery and a photovoltaic panel, offering an autonomous energy harvesting device for wireless components. The initial concept was designed to address opportunities in automotive and wearables, but publicity around the project has also attracted interest from consumer goods companies looking for innovative ways to promote their products in retail outlets.

 

The next product milestone on Ilika's Stereax roadmap is its industrial battery, code-named Endeavour, which will be able to operate in an extended temperature range covering -40 to 150 degree Celsius. This battery is designed to meet the requirements of Industrial IoT, sometimes called Industry 4.0. A discussion of applications is covered in our recently-posted video featuring Meggitt and IBM which can be found here - http://www.ilika.com/news/videos.

 

Materials development programmes

While the Company is deploying most of its operational and commercial resources on Stereax activities, it has also seen an increase in materials development programmes on its high throughput technology platform. Last month Ilika announced that it had received notification of a renewal of the commercial relationship it has with Seagate to develop photonic materials and processes for Hard Disk Drive ("HDD") technology.

 

Ilika has also recently announced the renewal and strengthening of its long-standing relationship with Toyota. This has been triggered by the award of a contract by the Toyota Research Institute in the USA, which was founded at the end of 2015 with an initial focus on artificial intelligence, robotics and materials innovation.

 

The Company will announce a more detailed update on the outturn for 2016/17 in May prior to issuing its full year results in July.

 

Graeme Purdy, CEO of Ilika, commented: "We are continuing to see a reinforcement of our customer relationships, with long-standing partnerships with companies like Toyota and Seagate being further cemented. It's also great to see the upturn in revenues relative to last year allowing us to start 2017/18 with such a strong order book. The number of potential licensees, their level of interest and the diversity of applications is giving us growing confidence in our licensing model."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan/ Paul Gillam (Corporate Adviser)

 

James Black/ Michael Burke (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDXCBBBGRR
Date   Source Headline
14th Jun 20184:35 pmRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSGrants supported by the Faraday Battery Challenge
12th Jun 20182:15 pmRNSGrant funding from Faraday Battery Challenge
23rd Apr 20187:00 amRNSChange of Nominated Adviser and Broker
20th Mar 201811:50 amRNSTechnical collaboration (replacement)
20th Mar 20187:00 amRNSCollaboration with PragmatIC and Arm Holdings
6th Feb 20187:00 amRNSInvestor presentation
19th Jan 201811:50 amRNSHolding(s) in Company
17th Jan 201811:53 amRNSHolding(s) in Company
16th Jan 20189:22 amRNSHolding(s) in Company
15th Jan 20182:33 pmRNSHolding(s) in Company
15th Jan 20182:28 pmRNSHolding(s) in Company
9th Jan 20187:00 amRNSHalf-year Report
6th Dec 20177:00 amRNSNotice of Results
4th Dec 20174:20 pmRNSHolding(s) in Company
21st Nov 20177:00 amRNSTrading Update
15th Nov 20173:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSPartnership with Wind Turbine Manufacturer
17th Oct 20177:00 amRNSHolding(s) in Company
12th Oct 20173:52 pmRNSHolding(s) in Company
28th Sep 20172:58 pmRNSResult of AGM
28th Sep 20177:00 amRNSAGM Statement
22nd Sep 201711:10 amRNSHolding(s) in Company
21st Sep 20173:52 pmRNSHolding(s) in Company
1st Sep 20177:00 amRNSPosting of Annual Report & Notice of AGM
30th Aug 201711:58 amRNSHolding(s) in Company
15th Aug 20175:18 pmRNSAward of bonus share options
11th Jul 20177:00 amRNSFinal Results
10th Jul 201710:19 amRNSHolding(s) in Company
29th Jun 20177:00 amRNSGrant of Fuel Cell Catalyst Patents in USA
22nd Jun 20177:00 amRNSInvestor results briefing
14th Jun 20177:00 amRNSNotice of Results
26th Apr 20177:00 amRNSProduct Enhancement
30th Mar 20172:30 pmRNSFurther information on TRI collaboration
23rd Mar 20177:00 amRNSPatent grant for solid-state batteries in USA
17th Mar 20176:25 pmRNSReplacement: Trading update
17th Mar 20177:00 amRNSTrading update
14th Mar 20177:00 amRNSCollaboration with Galvani Bioelectronics
9th Mar 20177:00 amRNSToyota Funds Collaboration with Ilika
10th Feb 20179:18 amRNSHolding(s) in Company
2nd Feb 20177:00 amRNSMaterials development grant for Hard Disk Drives
31st Jan 20177:00 amRNSInvestor presentation
9th Jan 20177:00 amRNSHalf-year Report
14th Dec 20167:00 amRNSIoT collaboration
23rd Nov 20167:00 amRNSTrading update
20th Oct 20162:59 pmRNSHolding(s) in Company
18th Oct 201611:45 amRNSHolding(s) in Company
18th Oct 201610:10 amRNSHolding(s) in Company
17th Oct 20162:43 pmRNSResult of General Meeting
30th Sep 20167:00 amRNSPosting of Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.